Standout Papers

A six-item short-form survey for measuring headache impact: The HIT-6™ 2003 2026 2010 2018 966
  1. A six-item short-form survey for measuring headache impact: The HIT-6™ (2003)
    Mark Kosinski, Martha Bayliss et al. Quality of Life Research
  2. Efficacy and safety of eptinezumab in patients with chronic migraine (2020)
    Richard B. Lipton, Peter J. Goadsby et al. Neurology
  3. Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1) (2020)
    Messoud Ashina, Joel R. Saper et al. Cephalalgia

Immediate Impact

8 from Science/Nature 136 standout
Sub-graph 1 of 17

Citing Papers

Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis
2025 StandoutNature
Trigeminal ganglion neurons are directly activated by influx of CSF solutes in a migraine model
2024 StandoutScience
3 intermediate papers

Works of Roger Cady being referenced

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Symptoms of Cutaneous Sensitivity Pre-Treatment and Post-Treatment: Results from the Rizatriptan TAME Studies
2007
and 2 more

Author Peers

Author Last Decade Papers Cites
Roger Cady 7313 4991 3421 212 8.6k
Stewart J. Tepper 7486 4810 2874 277 8.9k
Gennaro Bussone 6193 4058 2739 269 7.8k
Dawn C. Buse 9709 5360 2749 199 10.5k
Peer Tfelt‐Hansen 5598 3195 2560 193 6.7k
Lars Jacob Stovner 7639 3656 2226 186 9.8k
Paolo Martelletti 6302 3486 2212 328 8.1k
Sheena K. Aurora 5411 3454 2286 110 6.5k
Zaza Katsarava 10201 6741 4077 231 12.7k
Massimo Leone 5320 3868 2850 197 6.7k
Alan M. Rapoport 5380 3355 2431 195 6.2k

All Works

Loading papers...

Rankless by CCL
2026